Skip to content
Clinical Trial Events
11th Annual Outsourcing in Clinical Trials & Clinical Trial Supply Korea 2026

Talk Stream A: Outsourcing & Clinical Operations track

CASE STUDY: AriBio’s AR1001: Korea’s First Global Blockbuster Candidate for Alzheimer’s

Wed, Dec 2, 2026 · 3:15–3:45 PM KST JW Marriott Dongdaemun Square Seoul

About this session

AR1001 is a first-in-class, oral, disease-modifying therapy poised to reshape Alzheimer's treatment after two decades of limited progress. We'll cover the scientific breakthroughs and strategic lessons behind its development. We'll highlight AriBio's focus on delivering the right therapy to the right patients, while meeting FDA and EMA regulatory standards.

Speaker